Annualized rate of an accidental allergic reaction (95% CI)
|
0.130
(0.109–0.153)
|
0.107
(0.082–0.136)
|
0.124
(0.094–0.161)
|
0.087
(0.044–0.151)
|
0.111
(0.053–0.204)
|
Annualized rate of anaphylaxis for accidental allergic reaction (95%
CI)
|
0.015
(0.009–0.025)
|
0.005
(0.001–0.014)
|
0.019
(0.009–0.037)
|
0.014
(0.002–0.052)
|
0.011
(0.0002–0.041)
|
Accidental allergic reactions, n |
148 |
61 |
57 |
12 |
8 |
Severity of symptoms, n (%) |
|
|
|
|
|
Mild |
65 (44%) |
24 (39%) |
27 (47%) |
4 (33%) |
4
(50%) |
Moderate |
76 (51%) |
32 (52%) |
29 (51%) |
7 (58%) |
4
(50%) |
Severe |
1 (0.7%) |
0 (%) |
1 (2%) |
0 (0%) |
0 (0%) |
Unknown |
6 (%) |
5 (8%) |
0 (0%) |
1 (8%) |
0 (0%) |
Symptoms, n (%) |
|
|
|
|
|
Skin |
68 (46%) |
25 (41%) |
29 (51%) |
5 (42%) |
4
(50%) |
Oral mucosal |
31 (21%) |
10 (16%) |
14 (25%) |
1 (8%) |
4
(50%) |
Respiratory |
32 (22%) |
9 (15%) |
16 (28%) |
4 (33%) |
1
(%) |
Gastrointestinal |
36 (24%) |
23 (38%) |
6 (11%) |
3 (25%) |
2
(25%) |
Cardiovascular |
3 (2%) |
1 (2%) |
2 (4%) |
0 (0%) |
0
(0%) |
Neurological |
3 (2%) |
2 (3%) |
0 (0%) |
0 (0%) |
1
(%) |
Treatments, n (%) |
|
|
|
|
|
Total treatments |
101 (68%) |
41 (67%) |
39 (68%) |
10 (83%) |
6
(75%) |
Antihistamine |
84 (57%) |
40 (66%) |
31 (54%) |
10 (83%) |
5
(63%) |
Steroids |
11 (7%) |
3 (5%) |
6 (11%) |
1 (8%) |
1
(13%) |
β2-agonist inhalation |
5 (3%) |
0 (0%) |
2 (4%) |
2 (17%) |
1
(13%) |
Intramuscular adrenaline |
6 (4%) |
0 (0%) |
6 (11%) |
0 (0%) |
0
(0%) |